Speaker illustration

Professor Alberto Corsini

University of Milan - Department of Pharmacological Sciences and Bio, Milan (Italy)

Clinical tolerability and safety profile of CER-001, a novel bio-engineered pre-beta HDL-mimetic, across the clinical development programs

Event: ESC Congress 2016

Topic: Drug therapy

Session: Lipid-lowering agents - New perspectives

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb